Tag

Gedea Biotech

Annette Säfholm

Gedea Biotech to Start EpHect Clinical Trial

May 27, 2022

Gedea Biotech has received regulatory …

Annette Säfholm

Gedea named Rapidus Company of the Year

May 2, 2022

Gedea Biotech has been named …

Annette Säfholm

Gedea completes recruitment for NEFERTITI trial

February 8, 2022

Gedea Biotech has successfully completed …

Annette Säfholm

Gedea receives funding for microbiome research project

December 22, 2021

Gedea Biotech has received funding …

Ton Berkien

Gedea Biotech appoints new Chair

December 1, 2021

Ton Berkien has been elected …

Annette Säfholm

Gedea Biotech granted European patent

October 27, 2021

The company has been granted …

Annette Säfholm

Gedea Biotech granted US patent

September 1, 2021

Gedea Biotech has been granted …

Annette Säfholm

Gedea adds three Swedish clinics to its ongoing study

March 10, 2021

Gedea Biotech has added three …

Annette Säfholm

First patient enrolled in Gedea study

February 17, 2021

Gedea Biotech has enrolled the …

Annette Säfholm

New findings about Gedea’s antibiotic-free treatment

December 17, 2020

Gedea Biotech has announced that …

Annette Säfholm

Gedea Biotech receives clinical trial approval

October 27, 2020

The company has received approval …

Annette Säfholm

Gedea Biotech receives certificate for preparation of CE marking

April 7, 2020

Gedea Biotech has received its …

Annette Säfholm

Gedea Biotech reports results from clinical study

March 12, 2020

Gedea Biotech, has reported results …

Annette Säfholm

Gedea Biotech reports last patient visit in vulvovaginal candidiasis clinical study

December 19, 2019

Gedea Biotech has announced that …

All patients treated in Gedea Biotech’s study in women with bacterial vaginosis

November 4, 2019

Gedea Biotech reports that all …